In the Tepezza MDL (No. 3079), the Court denied the plaintiffs’ motion to compel Horizon Therapeutics to produce six Patient Access Liaisons (PALs) and one sales representative for deposition. Plaintiffs argued these individuals had case-specific knowledge and should not count toward the 30-deposition cap set in Case Management Order No. 5. The Court rejected this, noting PALs were identified as custodians by August 2023 and plaintiffs delayed requesting related discovery. The Court found no “good cause” under Rule 30 to exceed the deposition limit, citing potential burden on the defendant and insufficient justification to modify the agreed-upon terms.
The first bellwether trials in this litigation are scheduled to run from April to September 2026. These initial cases will help assess potential settlement frameworks and inform broader legal strategies. While the outcomes won’t legally bind other claims, they are expected to significantly influence negotiations and future proceedings. A critical question remains: Will these trials compel Tepezza’s manufacturer to acknowledge alleged hearing damage claims, or will they persist in defensive legal tactics? Given jury tendencies in similar cases, substantial settlement offers may eventually follow.
The Tepezza multi-district litigation (MDL) will hold a crucial hearing on January 28, 2025, to determine which cases will be selected for the first three bellwether trials. Bellwether trials are vital in shaping the direction of the litigation, as their outcomes often provide valuable insights into the potential results of other cases. Should these trials favor plaintiffs, they may prompt settlement discussions later in 2025 or 2026, offering a path to resolution for those involved in the ongoing litigation.
In a recent ruling, the court addressed the plaintiffs’ motion from our previous update and issued a favorable decision. The court determined that the defense counsel’s objections were obstructive and unwarranted, particularly regarding document foundations. The judge noted that the documents produced during discovery implied authentication, making the defense’s repeated objections misplaced. Additionally, the court suggested that another defense attorney could have used a “running objection” instead of objecting repeatedly. While the specific details may not be crucial, this ruling helps clarify the dynamics of the case, indicating who is taking a more cooperative approach in the litigation.
Dozens of lawsuits have been filed against drug manufacturer Horizon Therapeutics regarding their medication Tepezza (teprotumumab-trbw). The drug is used to treat thyroid eye disease (TED), a condition associated with the autoimmune disorder Grave’s disease. TED can cause eye discomfort, pain, swelling, vision damage, and even blindness in severe cases.
Lawsuits state Tepezza caused patients to develop irreversible hearing loss, a side effect its manufacturer is accused of downplaying. Because of this alleged lack of transparency, those who took Tepezza for relief from debilitating vision problems are now facing the life-altering reality of hearing loss. Affected patients are filing lawsuits in the pursuit of justice and compensation, which courts have decided to consolidate into multidistrict litigation (MDL). This is good news for individuals affected by Tepezza, who can now join together to fight to hold Horizon Therapeutics accountable.
If you or a loved one were harmed by taking Tepezza, you may be feeling devastated and overwhelmed. It’s important to understand that you have legal rights and may be eligible to file a lawsuit against Horizon Therapeutics. In this article, you’ll learn about prequalifying injuries and how to take the first steps toward justice today.
Tepezza’s approval in 2020 was a light in the dark for patients suffering from thyroid eye disease (TED). Many viewed the drug, which is given to patients via infusion, as the key to freedom from the debilitating eye problems associated with TED. Tepezza works by blocking insulin-like growth factor 1 receptor (IGF-1R), a protein found on the surface of human cells that contributes to the disease.
Sadly, these hopes were soon shattered when droves of patients began experiencing serious hearing problems like tinnitus, hypersensitivity to sounds, partial and total hearing loss, and more. For many affected patients, these side effects are permanent, leaving victims to endure the heartbreaking reality of lifelong hearing impairment.
In addition to hearing damage, the FDA associates Tepezza with side effects like:
Documentation revealed that Horizon Therapeutics appears to have been aware of Tepezza’s potential to affect hearing, sparking a wave of lawsuits across the country. Initial drug trials showed that hearing loss affected around 10% of patients taking Tepezza, but recent research showed this figure might be concerningly low; a study by the Endocrine Society revealed that the rate of patients who suffered hearing loss might be as high as 65%. Thousands of patients have taken Tepezza, leaving many at risk of serious side effects.
Plaintiffs have accused Horizon Therapeutics of endangering the health of patients by:
Lawsuits focus on these allegations as plaintiffs fight to hold Horizon Therapeutics accountable for their pain and suffering.
The Tepezza hearing loss lawsuit is for any patient who was administered Tepezza (teprotumumab-trbw) and went on to suffer from hearing-related side effects. With the help of their attorneys, patients should be ready to compile evidence documenting their injuries, like medical records, personal statements, and prescription details. Proof of costs related to the injury, including medical bills and receipts, is also helpful in proving the financial impact.
To join the Tepezza lawsuit, patients must meet a number of requirements. While every case is different and each person should consult an attorney to determine whether they qualify, common factors determining qualification include:
Qualifying hearing-related side effects include:
Additionally, other injuries that may prequalify you for the Tepezza lawsuit are:
If you are considering exercising your legal rights after being harmed by Tepezza, you may be concerned about the cost of securing legal representation. Fortunately, most lawyers who work on MDL cases do not require payment up front. Instead, your lawyer is paid a percentage of your compensation if you win your case. This is called working on a contingency fee basis, and it makes hiring an attorney accessible regardless of financial limitations. Your attorney can answer any questions you have about legal fees and how they are paid.
Factors like what state you live in, when you discovered your hearing loss, and more will determine the deadline to file your claim. This is called the statute of limitations, and an attorney can help you determine which deadlines apply to you.
Lawyers are ready to speak with you about whether you may qualify for the Tepezza hearing loss lawsuit. Fill out the form at the top of the page today to connect with an attorney in the OCA network who can help you begin pursuing the compensation you deserve.
This is an advertisement. OnlyClassActions is not a law firm or referral service, and we do not provide legal advice. OnlyClassActions provides a free service for individuals seeking legal representation, and we do not charge you to be connected with an attorney. We do not recommend or endorse any attorneys that pay to participate. OnlyClassActions utilizes a pool of attorneys in each jurisdiction, and attorneys are selected through a round-robin process without our evaluating your legal situation when selecting which attorney will receive your information. OnlyClassActions makes no representation about the quality of legal services or the qualifications of any attorney participating in our pool. Information you submit will be shared with third-party attorney(s). An attorney-client relationship is not formed when you submit information through the form. Hiring a lawyer is a critical decision and should not be predicated solely on comments, advertisements, or other content found on any website. You are under no obligation to retain a lawyer who contacts you through this service.
Join our newsletter to stay up to date on cases and settlements.
Add Comment